Clinical trial · Observational
Estimation of the Tissue and Serum Levels of Interleukin (IL) -35 in Mycosis Fungoides: a Case Control Study
Estimation of the Tissue and Serum Levels of Interleukin (IL) -35 in Mycosis Fungoides: a Case Control Study.
NCT05855460CI-TRIAL-00066361unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Tissue and serum samples from 20 MF patients and 20 normal healthy controls will be subjected for biochemical assessments by ELISA (Enzyme- linked immune-sorbent assay) for assessing the level of IL35.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Mycosis Fungoides | Mycosis Fungoides | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Skin biopsy | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Mycosis fungoides patients
- description
- Blood sample and skin biopsy for assessment of IL35 by ELISA
- interventionNames
- Diagnostic Test: Skin biopsy
- label
- Normal healthy controls
- description
- Blood sample and skin biopsy for assessment of IL35 levels by ELISA
- interventionNames
- Diagnostic Test: Skin biopsy
Primary outcomes (1)
- measure
- To assess and compare tissue and serum levels of interleukin 35 (IL -35) in mycosis fungoides patients and normal controls.
- timeFrame
- 1 year
- description
- To assess and compare tissue and serum levels of interleukin 35 (IL -35) in mycosis fungoides patients and normal controls.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with mycosis fungoides. Both genders. Age group ≥ 18 years old. Exclusion Criteria: * Patients with any other skin diseases. Patients who received treatments for mycosis fungoides in the past three months. Subjects with history of solid or hematological malignancy as leukemia
References
Publications (0)
Data not yet available
No reference posted for this study.